Hahnemann Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in New Delhi, Delhi, India, established in 1996.
1996 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Hahnemann Pharmaceuticals Private Limited

Hahnemann Pharmaceuticals Private Limited, a active private limited company, was established on 14 July 1996 in New Delhi, Delhi, India. Engaging in alternative & holistic medicine within the manufacturing sector, it holds CIN: U24232DL1996PTC080135. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.49 M.

It upholds a compliant status. Its leadership includes Neeru Narula (Director), Karan Narula (Additional Director), Pooja Narula (Director). It holds ₹8.30 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A-7 Naraina Industrial Area Phase-I, New Delhi, Delhi, 110028.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL1996PTC080135

  • Registration Number

    080135

  • Incorporation Date

    14 July 1996

  • Authorized Capital

    ₹2.00 M

  • Paid-Up Capital

    ₹0.49 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 0.49 M
  • Company Age 29 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.30 M
  • Revenue Growth **** -1.02%
  • Profit Growth **** -69.44%
  • Ebitda **** -23.58%
  • Net Worth -10.40%
  • Total Assets -21.29%
Company report

Hahnemann Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hahnemann Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Hahnemann Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Neeru Narula Director 14 Jul 1996 Current
Karan Narula Additional Director 02 Sep 2019 Current
Pooja Narula Director 14 Jul 1996 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hahnemann Pharmaceuticals.

Hahnemann Pharmaceuticals Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 1.02% decrease. The company also saw a substantial fall in profitability, with a 69.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.4%.

Hahnemann Pharmaceuticals revenue growth over time
Hahnemann Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -1.02%
*******
*******
*******
*******
Revenue from Operations
*******
 -0.77%
*******
*******
*******
*******
Total Assets
*******
 -21.29%
*******
*******
*******
*******
Profit or Loss
*******
 -69.44%
*******
*******
*******
*******
Net Worth
*******
 -10.40%
*******
*******
*******
*******
EBITDA
*******
 -23.58%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hahnemann Pharmaceuticals?

In 2017, Hahnemann Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹8,300,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Bank Of India : 0.53 Cr
  • The Jammu & Kashmir Bank Ltd. : 0.16 Cr
  • Union Bank Of India : 0.09 Cr
  • Uco Bank : 0.05 Cr
Latest Charge Details
Date Lender Amount Status
29 Mar 2005 Bank Of India ₹5.30 M Open
20 Dec 2002 The Jammu & Kashmir Bank Ltd. ₹1.60 M Open
06 Jan 2000 Uco Bank ₹0.50 M Open
11 Sep 1997 Union Bank Of India ₹0.90 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Hahnemann Pharmaceuticals?

Unlock and access historical data on people associated with Hahnemann Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hahnemann Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hahnemann Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hahnemann Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Hahnemann Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Hahnemann Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Karan Narula was appointed as a Additional Director was appointed as a Additional Director on 02 Sep 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Bank Of India amounted to Rs. 5.30 M with Charge ID 90059013 was registered on 29 Mar 2005. was documented.

  • Charges

    Progress on A charge with The Jammu & Kashmir Bank Ltd. amounted to Rs. 1.60 M with Charge ID 90057944 was registered on 20 Dec 2002. was documented.

  • Charges

    A charge with Uco Bank amounted to Rs. 0.50 M with Charge ID 90057164 was registered on 06 Jan 2000. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hahnemann Pharmaceuticals Private Limited?

The CIN of Hahnemann Pharmaceuticals Private Limited is U24232DL1996PTC080135.

Where is Hahnemann Pharmaceuticals Private Limited headquartered?

Hahnemann Pharmaceuticals Private Limited is headquartered at A-7 Naraina Industrial Area Phase-I, New Delhi, Delhi, 110028.

When was Hahnemann Pharmaceuticals Private Limited incorporated?

Hahnemann Pharmaceuticals Private Limited was incorporated on 14 July 1996.

Who are the current directors of Hahnemann Pharmaceuticals Private Limited?

The current directors of Hahnemann Pharmaceuticals Private Limited are

What is the primary industry of Hahnemann Pharmaceuticals Private Limited?

The primary industry of Hahnemann Pharmaceuticals Private Limited is Manufacturing.

Is Hahnemann Pharmaceuticals Private Limited a listed company?

Hahnemann Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Hahnemann Pharmaceuticals Private Limited?

The authorized capital of Hahnemann Pharmaceuticals Private Limited is ₹2.00 M, and the paid-up capital is ₹0.49 M.

What is the compliance status of Hahnemann Pharmaceuticals Private Limited?

The compliance status of Hahnemann Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available